STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Aclaris Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Aclaris Therapeutics (NASDAQ: ACRS) said CEO Dr. Neal Walker and senior leadership will join a fireside chat at the Piper Sandler 37th Annual Healthcare Conference in New York City.

The discussion is scheduled for Tuesday, December 2, 2025 at 11:00 AM EST. A live and archived webcast will be available on the company Events page at aclaristx.com and will remain accessible for at least 30 days.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

WAYNE, Pa., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that Dr. Neal Walker, Aclaris’ Chief Executive Officer and other members of Aclaris’ senior leadership team will participate in a fireside chat during the Piper Sandler 37th Annual Healthcare Conference in New York City. The discussion will take place on Tuesday December 2, 2025 at 11:00 AM EST.

A live and archived webcast will be accessible on the Events page of https://www.aclaristx.com/. The webcast will be available on the Aclaris website for at least 30 days.

About Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel product candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of product candidates powered by a robust R&D engine. For additional information, please visit www.aclaristx.com and follow Aclaris on X (formerly Twitter) at @AclarisTx and on LinkedIn.

Aclaris Therapeutics Contact:

Will Roberts
Senior Vice President
Corporate Communications and Investor Relations
(484) 329-2125
wroberts@aclaristx.com


FAQ

When will Aclaris (ACRS) present at the Piper Sandler 2025 healthcare conference?

Aclaris will present on Tuesday, December 2, 2025 at 11:00 AM EST.

Who from Aclaris (ACRS) will participate in the Piper Sandler fireside chat?

CEO Dr. Neal Walker and other senior leadership will participate in the fireside chat.

How can investors watch the Aclaris (ACRS) Piper Sandler presentation?

A live webcast and archived replay will be accessible on the company Events page at aclaristx.com.

How long will the Aclaris (ACRS) webcast remain available online?

The webcast will be available on the Aclaris website for at least 30 days after the event.

What is the focus of Aclaris Therapeutics (ACRS) as described for the conference participation?

Aclaris is described as a clinical-stage biopharmaceutical company focused on developing product candidates for immuno-inflammatory diseases.
Aclaris Therapeutics Inc

NASDAQ:ACRS

ACRS Rankings

ACRS Latest News

ACRS Latest SEC Filings

ACRS Stock Data

295.78M
105.43M
2.69%
86.19%
5.46%
Biotechnology
Pharmaceutical Preparations
Link
United States
WAYNE